H.U. Group Holdings, Inc.

4544.T
Diagnostics & Research
2026/08/21 Updated
Market Cap: $1.2B (¥198.3B)
Stock Price: $22.85 (¥3,632)
Exchange Rate: 1 USD = ¥158.98

First Quarter Financial Results for the Fiscal Year Ending March 2027 (Japanese GAAP) (Consolidated)

First-quarter net sales were 62,590 million yen, up 1.9% YoY. Operating income 2,099 million yen, ordinary income 2,137 million yen, net income attributable to owners of parent 1,574 million yen. By segment, clinical diagnostics grew in sales, examinations and related services improved profitability, and healthcare declined in sales and profit. Full-year forecast unchanged. Due to treasury stock acquisition, equity ratio declined to 51.1%.

Importance:
Page Updated: August 12, 2026
IR Disclosure Date: August 12, 2026

Key Figures

  • Net sales: 62,590 million yen (YoY +1.9%)
  • Operating income: 2,099 million yen (YoY +141.1%)
  • Ordinary income: 2,137 million yen
  • Net income attributable to owners of parent: 1,574 million yen
  • Equity ratio: 51.1% (vs prior year -0.2%)

AI要約

Overview of performance

Total net sales for this quarter were 62,590 million yen, supported by growth in the clinical diagnostics business, including currency effects, and pricing normalization in examinations and related services, achieving higher sales. Operating income was 2,099 million yen and ordinary income 2,137 million yen, turning profitable. By segment, clinical diagnostics remained solid, examinations and related services grew in sales and reduced fixed costs to stay profitable. Healthcare-related services declined in sales and profit due to the impact of stock transfers. The full-year forecast remains unchanged.

Financial position and outlook

Total assets at the end of the first quarter were 263,004 million yen, net assets 134,644 million yen, and equity ratio 51.1%. Cash and cash equivalents decreased, but cash flow from operations amounted to 2,889 million yen. Meanwhile, net assets decreased due to treasury stock acquisition and dividend payments. The full-year earnings guidance remains as announced.

Net Sales Trend

Operating Income Trend

Segment Net Sales

Segment Operating Income

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

H.U. Group Holdings, Ltd.

Company overview · Stock price · Financial data · All IR

View company page →